Safety and clinical outcomes of transarterial microembolization for accessory navicular syndrome refractory to conservative treatment.

IF 2.4 3区医学 Q2 ORTHOPEDICS

Foot and Ankle Surgery Pub Date : 2026-07-04 DOI:10.1016/j.fas.2026.06.018

Takatoshi Kubo, Ahmed Farhan, Masahiko Shibuya, Koichi Miyazaki, Masaya Nakata, Atsuhiko Kawabe, Takashi Nakasone, Yoshiaki Shintani, Tomokazu Tajima, Yuji Okuno

{"title":"Safety and clinical outcomes of transarterial microembolization for accessory navicular syndrome refractory to conservative treatment.","authors":"Takatoshi Kubo, Ahmed Farhan, Masahiko Shibuya, Koichi Miyazaki, Masaya Nakata, Atsuhiko Kawabe, Takashi Nakasone, Yoshiaki Shintani, Tomokazu Tajima, Yuji Okuno","doi":"10.1016/j.fas.2026.06.018","DOIUrl":null,"url":null,"abstract":"Background: Transarterial microembolization (TAME) relieves pain by embolizing inflammatory neovessels. As inflammation is a key driver of pain in accessory navicular syndrome (ANS), TAME may be a therapeutic option for patients refractory to conservative management.Methods: We retrospectively analyzed 75 patients (36 females; mean age, 23 ± 15 years) with refractory ANS treated with TAME (Sep 2020-Aug 2024). Adverse events were recorded. Outcomes were assessed using Numeric Rating Scale (NRS) and European Foot and Ankle Society (EFAS) scores.Results: No major complications were observed. Mean NRS improved from 6.9 ± 1.5 at baseline to 1.6 ± 2.1 at 12 months and 1.4 ± 1.9 at final assessment (mean 31 ± 13 months) (p < 0.001). Mean EFAS scores increased from 7.6 ± 5.1-18.8 ± 6.0 at 12 months and 20.3 ± 5.5 finally (p < 0.001).Conclusions: TAME demonstrated a favorable safety profile and provided durable symptomatic relief for ANS.Level of evidence: IV.","PeriodicalId":48743,"journal":{"name":"Foot and Ankle Surgery","volume":" ","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2026-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Foot and Ankle Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.fas.2026.06.018","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ORTHOPEDICS","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Transarterial microembolization (TAME) relieves pain by embolizing inflammatory neovessels. As inflammation is a key driver of pain in accessory navicular syndrome (ANS), TAME may be a therapeutic option for patients refractory to conservative management.

Methods: We retrospectively analyzed 75 patients (36 females; mean age, 23 ± 15 years) with refractory ANS treated with TAME (Sep 2020-Aug 2024). Adverse events were recorded. Outcomes were assessed using Numeric Rating Scale (NRS) and European Foot and Ankle Society (EFAS) scores.

Results: No major complications were observed. Mean NRS improved from 6.9 ± 1.5 at baseline to 1.6 ± 2.1 at 12 months and 1.4 ± 1.9 at final assessment (mean 31 ± 13 months) (p < 0.001). Mean EFAS scores increased from 7.6 ± 5.1-18.8 ± 6.0 at 12 months and 20.3 ± 5.5 finally (p < 0.001).

Conclusions: TAME demonstrated a favorable safety profile and provided durable symptomatic relief for ANS.

Level of evidence: IV.

查看原文本刊更多论文

经动脉微栓塞治疗保守治疗难治性副舟状综合征的安全性和临床效果。

背景：经动脉微栓塞（TAME）通过栓塞炎性新血管来缓解疼痛。由于炎症是副舟骨综合征（ANS）疼痛的关键驱动因素，TAME可能是保守治疗难治性患者的一种治疗选择。方法：回顾性分析75例（女性36例，平均年龄23 ± 15岁）经TAME治疗的难治性ANS患者（2020年9月- 2024年8月）。记录不良事件。采用数值评定量表（NRS）和欧洲足踝协会（EFAS）评分对结果进行评估。结果：无重大并发症。意味着评分从6.9提高 ±1.5 从基线值的1.6 ±2.1  12个月和1.4±1.9 最终评估(平均31 ± 13个月)(p 结论:驯服提供持久的症状表现出良好的安全性和减免证据ANS.Level:第四。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Foot and Ankle Surgery ORTHOPEDICS-

CiteScore

4.60

自引率

16.00%

发文量

202

期刊介绍： Foot and Ankle Surgery is essential reading for everyone interested in the foot and ankle and its disorders. The approach is broad and includes all aspects of the subject from basic science to clinical management. Problems of both children and adults are included, as is trauma and chronic disease. Foot and Ankle Surgery is the official journal of European Foot and Ankle Society. The aims of this journal are to promote the art and science of ankle and foot surgery, to publish peer-reviewed research articles, to provide regular reviews by acknowledged experts on common problems, and to provide a forum for discussion with letters to the Editors. Reviews of books are also published. Papers are invited for possible publication in Foot and Ankle Surgery on the understanding that the material has not been published elsewhere or accepted for publication in another journal and does not infringe prior copyright.